diabetes care News
-
CeQur Acquires Assets from Calibra Medical, Inc.
CeQur today announced that the company has acquired select assets of Calibra Medical, Inc., one of the Johnson & Johnson Diabetes Care Companies. The transaction includes an exclusive worldwide license for the wearable, on-demand insulin delivery system previously known as OneTouch Via™. The Calibra system enables people with diabetes to discreetly and conveniently deliver rapid-acting ...
-
ReportAlert.info - Novo Nordisk (CPH:NOVO.B) publishes 2010 annual report
Novo Nordisk, the world leader in diabetes care, has released its seventh annual integrated report with 2010 results. The company’s achievements for the year include solid sales growth, progress in clinical development programmes, healthcare system capacity building, and reductions in resource consumption and CO2 emissions. During 2010, Novo Nordisk: Increased sales by 13% (in local ...
By 3BL Media
-
Ascensia Diabetes Care Announces Fda Approval Of The Eversense E3 Continuous Glucose Monitoring System For Use For Up To Six Months
Ascensia Diabetes Care, a global diabetes company, announces that its partner Senseonics has received approval from the U.S. Food and Drug Administration (FDA) of the next-generation Eversense® E3 continuous glucose monitoring (CGM) System. Ascensia plans to make the E3 sensor, which can be used for up to six months, available to patients in the U.S. during the second quarter of 2022. Robert ...
By Senseonics
-
Senseonics Announces Business Updates
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced operational and financial business updates. Operational and Financial Updates Substantive review with the FDA for the PMA supplement for the next generation ...
By Senseonics
-
Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults
Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced real-world data confirming that use of the t:slim X2™ insulin pump with Control-IQ® advanced hybrid closed-loop technology resulted in immediate and ongoing improvements in glycemic control, quality of life outcomes, and user-reported reduced burden of diabetes management.1 The ...
-
2,000,000 TWO2 Treatments Milestone Reached as TWO2 Study Is Highlighted in Systemic Review of Topical Oxygen Therapies
Advanced Oxygen Therapy Inc. (AOTI) today announced that 2,000,000 treatments of its unique cyclical-pressure Topical Wound Oxygen (TWO2) therapy have now been applied by patients safely at home. Additionally, a high-quality paper published on April 19, 2021 in the journal Diabetic Medicine, entitled Topical oxygen therapy for diabetes-related foot ulcers: A systematic review and ...
-
Modular Medical Expands Executive Team with Appointment Of Lynn O`Connor Vos as New CEO
Modular Medical, Inc. (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced the expansion of its executive team with the appointment of Lynn O'Connor Vos as its new Chief Executive Officer. The company's ...
-
Modular Medical to Present at LD Micro Invitational XII Investor Conference
Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, is scheduled to present at the LD Micro Invitational XII Investor Conference on Wednesday, June 8, 2022 ...
-
New training manual for treatment of type 1 diabetes in children in developing countries
In collaboration with the International Society for Pediatric and Adolescent Diabetes (ISPAD) Novo Nordisk has today launched a training manual specific to the diagnosis and treatment of diabetes care for children in developing countries. Unveiled on the opening day of the ISPAD Congress 'ISPAD 2010', which is currently taking place in Buenos Aires, this first edition of the manual is available ...
-
Modular Medical Announces Participation at Upcoming Investor Conferences
Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, will be participating in the following investor conferences: Piper Sandler 34th Annual Healthcare ...
-
African health leaders gather to address significant rise in diabetes
With the incidence of diabetes rising at an alarming rate worldwide, UN member states have resolved to host a summit in 2011 on this growing healthcare threat. In preparation for this, South Africa hosted the Diabetes Leadership Forum Africa 2010 (DLFA) in Johannesburg on 30 September and 1 October. The forum, which was co-hosted by the South African Ministry of Health and the World Diabetes ...
-
Modular Medical Announces Product Testing Update
Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced an update on the development of its initial insulin pump product. The Company has continued to make progress on the testing required for its 510(k) submission ...
-
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market
Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced a "reverse split" of its shares of common stock at a ratio of 1-for-3. The Company's common stock will begin ...
-
McKesson foundation awards $1.5 million to researchers studying how mobile technology can help patients manage diabetes
The McKesson Foundation today announced the six recipients of $1.5 million in research grants as part of its Mobilizing for Healthsm initiative to improve the health of underserved populations with chronic diseases through the use of mobile-phone technology. The Mobilizing for Healthsm grants, of up to $250,000 each, will support studies on diabetes care and management at six esteemed U.S. ...
By 3BL Media
-
Modular Medical Provides Product Update
Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today provided an update on its insulin pump product. The Company has successfully completed the majority of the tests and documentation required for its 510(k) submission ...
-
Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market
Modular Medical, Inc., (NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, announced today the pricing of its underwritten public offering of 2,500,000 units at a price to the public ...
-
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.
Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced the expansion of its Board of Directors with the appointment of two independent directors, ...
-
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
Modular Medical, Inc. (the "Company" or "Modular Medical")(NASDAQ:MODD) today announced that it has appointed industry veteran Kevin Schmid as its Chief Operating Officer. Mr. Schmid brings extensive operations and business development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet Corporation, he was instrumental in the ...
-
AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population
Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration (NMPA), commonly referred to as China FDA, approval for its unique cyclically pressurized Topical Wound Oxygen (TWO2) therapy. Making it the only advanced sustained wound healing therapeutic to have ...
-
Inflammatix Appoints Dr. Kian Beyzavi as New Board Member
Inflammatix, a pioneering molecular diagnostics company, announced today the appointment of Kian Beyzavi, PhD, as an independent member of the company’s board of directors. Dr. Beyzavi is a seasoned veteran of the healthcare industry with significant operating experience in the medical device and diagnostics industries, and a focus on leveraging innovative technologies to improve diagnosis ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you